ADIL logo

Adial Pharmaceuticals, Inc. (ADIL)

Profile

Full Name

Adial Pharmaceuticals, Inc.

Ticker

NASDAQ: ADIL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 27, 2018

Indexes

Not included

Website

https://www.adial.com

Employees

5

Key Details

Price

$0.39(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$2.72(+24.44% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.39
    ADIL price is $0.39

    30-Day Relative Volume

    0.20
    ADIL 30-day relative volume is 0.20

    Price Performance

    Price Most recent change

    0%
    ADIL price has remained unchanged on Aug 15, 2025

    Price YTD change

    -61.39%
    ADIL price is down -61.39% since January 1st

    Price 1-year change

    -59.79%
    ADIL price is down -59.79% year-on-year

    Price 3-year change

    -97.4%
    ADIL price is down -97.4% over the past 3 years

    Price Range

    Price All-time high

    $236.00
    ADIL price is currently -99.83% below its historical high of $236.00

    Price 3-year low

    $0.22
    ADIL price is currently +77.27% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.51M
    ADIL market capitalization is $8.51 million

    Market cap 3-year change

    -45.12%
    ADIL market capitalization is down -45.12% over the past 3 years

    Market cap All-time high

    $94.79M
    ADIL market capitalization is currently -91.02% below its historical high of $94.79 million

    Market cap sector rank

    14.84%
    ADIL market capitalization is higher than 14.84% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +240.88%
    ADIL shares outstanding is up +240.88% year-on-year

    Shares Outstanding 3-Year Change

    +2010.64%
    ADIL shares outstanding is up +2010.64% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.61
    ADIL beta is 0.61

    200-day SMA

    $0.74
    ADIL price is currently -47.45% below its 200-day simple moving average

    50-day SMA

    $0.41
    ADIL price is currently -4.36% below its 50-day simple moving average

    RSI

    44.70
    ADIL 14-day relative strength index is 44.70

    Volume

    0.20
    ADIL 30-day relative volume is 0.20

    ATR

    $0.05
    ADIL average true range is $0.05

    10-day Historical Volatility

    72.65%
    ADIL 10-day historical volatility is 72.65%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ADIL annual revenue is $0.00

    Revenue Analysts estimate

    -
    ADIL annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ADIL annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.58%
    ADIL annual revenue is higher than 28.58% of companies in Healthcare sector

    EPS

    EPS

    -$2.72
    ADIL annual earnings per share is -$2.72

    EPS Analysts estimate

    -$0.68
    ADIL annual earnings per share is currently +300.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +24.44%
    ADIL annual earnings per share is up +24.44% year-on-year

    EPS Sector rank

    31.45%
    ADIL annual earnings per share is higher than 31.45% of companies in Healthcare sector

    Profit

    Gross profit

    -$600.00
    ADIL annual gross profit is -$600.00

    Gross margin

    -
    ADIL annual gross profit margin value is unknown

    Operating profit

    -$8.28M
    ADIL annual operating income is -$8.28 million

    Operating margin

    -
    ADIL annual operating profit margin value is unknown

    Net income

    -$13.20M
    ADIL annual net profit is -$13.20 million

    Net margin

    -
    ADIL annual net profit margin value is unknown

    Expenses

    Total expenses

    $8.28M
    ADIL annual total expenses is $8.28 million

    Operating expenses

    $8.28M
    ADIL annual total operating expenses is $8.28 million

    Cost of goods sold

    $600.00
    ADIL annual cost of goods sold is $600.00

    Selling, general & administrative expenses

    $5.06M
    ADIL annual SGA is $5.06 million

    Depreciation and amortization

    $600.00
    ADIL annual depreciation & amortization is $600.00

    Interest expense

    $0.00
    ADIL annual interest expense is $0.00

    Income tax

    $0.00
    ADIL annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$8.28M
    ADIL annual earnings before interest & taxes is -$8.28 million

    EBITDA

    -$8.28M
    ADIL annual EBITDA is -$8.28 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.08M
    ADIL annual total assets is $5.08 million

    Non current assets

    $985.20K
    ADIL annual long term assets is $985.20 thousand

    Current assets

    $4.06M
    ADIL annual total current assets is $4.06 million

    Cash and cash equivalents

    $3.75M
    ADIL annual cash & cash equivalents is $3.75 million

    Accounts receivable

    -
    ADIL annual accounts receivable value is unknown

    Inventory

    $0.00
    ADIL annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.01M
    ADIL annual total liabilities is $1.01 million

    Long term liabilities

    $0.00
    ADIL annual total long term liabilities is $0.00

    Current liabilities

    $975.90K
    ADIL annual total current liabilities is $975.90 thousand

    Accounts payable

    $298.40K
    ADIL annual accounts payable is $298.40 thousand

    Debt

    Total debt

    $0.00
    ADIL annual total debt is $0.00

    Total debt 1-year change

    0%
    ADIL annual total debt has remained unchanged year-on-year

    Long term debt

    -
    ADIL annual long term debt value is unknown

    Short term debt

    -
    ADIL annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $4.07M
    ADIL annual stockholders equity is $4.07 million

    Book value

    $4.07M
    ADIL annual book value is $4.07 million

    Retained earnings

    -$82.00M
    ADIL annual retained earnings is -$82.00 million

    Working capital

    $3.08M
    ADIL annual working capital is $3.08 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.92M
    ADIL annual cash flow from operations is -$6.92 million

    Cash from operations 1-year change

    -1.7%
    ADIL annual cash flow from operations is down -1.7% year-on-year

    Cash from investing

    $0.00
    ADIL annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    ADIL annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $7.85M
    ADIL annual cash flow from financing activities is $7.85 million

    Cash from financing 1-year change

    +89.87%
    ADIL annual cash flow from financing activities is up +89.87% year-on-year

    CAPEX

    CAPEX

    $0.00
    ADIL annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    ADIL annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$6.92M
    ADIL annual free cash flow is -$6.92 million

    Free cash flow 1-year change

    -1.7%
    ADIL annual free cash flow is down -1.7% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ADIL annual gross profit margin value is unknown

    Operating margin

    -
    ADIL annual operating profit margin value is unknown

    Net margin

    -
    ADIL annual net profit margin value is unknown

    ROA & ROE

    ROA

    -268.81%
    ADIL annual return on assets is -268.81%

    ROE

    -323.80%
    ADIL annual return on equity is -323.80%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ADIL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ADIL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.52
    ADIL price to book ratio is 1.52

    PB ratio Sector rank

    47.25%
    ADIL price to book ratio is higher than 47.25% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ADIL price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ADIL price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    ADIL enterprise value value is unknown

    Enterprise value Sector rank

    -
    ADIL enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    ADIL EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    ADIL EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.16
    ADIL annual current ratio is 4.16

    Quick ratio

    4.16
    ADIL annual quick ratio is 4.16

    Leverage

    Debt to equity

    0.00
    ADIL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ADIL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ADIL piotroski f-score value is unknown

    Altman Z-Score

    -22.20
    ADIL altman z-score is -22.20

    Analyst ratings

    Recent major analysts updates

    Nov 14, 24 Rodman & Renshaw
    Buy
    Jul 11, 23 Brookline Capital
    Buy
    Aug 17, 22 Maxim Group
    Hold
    Oct 13, 21 Brookline Capital
    Buy
    Jun 29, 21 Litchfield Hills
    Buy

    Institutional Ownership

    Screeners with ADIL included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Adial Pharmaceuticals, Inc.?
    • Does Adial Pharmaceuticals, Inc. pay dividends?
    • What sector is Adial Pharmaceuticals, Inc. in?
    • What industry is Adial Pharmaceuticals, Inc. in?
    • What country is Adial Pharmaceuticals, Inc. based in?
    • When did Adial Pharmaceuticals, Inc. go public?
    • Is Adial Pharmaceuticals, Inc. in the S&P 500?
    • Is Adial Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Adial Pharmaceuticals, Inc. in the Dow Jones?
    • When was Adial Pharmaceuticals, Inc.'s last earnings report?
    • When does Adial Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Adial Pharmaceuticals, Inc.?

    The ticker symbol for Adial Pharmaceuticals, Inc. is NASDAQ:ADIL

    Does Adial Pharmaceuticals, Inc. pay dividends?

    No, Adial Pharmaceuticals, Inc. does not pay dividends

    What sector is Adial Pharmaceuticals, Inc. in?

    Adial Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Adial Pharmaceuticals, Inc. in?

    Adial Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Adial Pharmaceuticals, Inc. based in?

    Adial Pharmaceuticals, Inc. is headquartered in United States

    When did Adial Pharmaceuticals, Inc. go public?

    Adial Pharmaceuticals, Inc.'s initial public offering (IPO) was on July 27, 2018

    Is Adial Pharmaceuticals, Inc. in the S&P 500?

    No, Adial Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Adial Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Adial Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Adial Pharmaceuticals, Inc. in the Dow Jones?

    No, Adial Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Adial Pharmaceuticals, Inc.'s last earnings report?

    Adial Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2025

    When does Adial Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Adial Pharmaceuticals, Inc. is November 13, 2025
    On this page